Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference, in the Prospectus constituting a part of this Amendment No. 2 to the Registration Statement (No. 333-226841) on Form S-1, of our report dated March 30, 2019, relating to the financial statements of Titan Pharmaceuticals, Inc., appearing in Amendment No. 1 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2018. Our report contains an explanatory paragraph expressing substantial doubt about the Company’s ability to continue as a going concern.
We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ OUM & CO. LLP
San Francisco, California
October 8, 2019
